{"id":10511,"date":"2025-10-08T19:19:10","date_gmt":"2025-10-09T00:19:10","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=10511"},"modified":"2025-10-08T19:19:14","modified_gmt":"2025-10-09T00:19:14","slug":"bavarian-nordic-reveals-positive-mpox-vaccine-trial-data-in-children","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2025\/10\/08\/bavarian-nordic-reveals-positive-mpox-vaccine-trial-data-in-children\/","title":{"rendered":"Bavarian Nordic reveals positive mpox vaccine trial data in children"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/bavarian-nordic-positive-mpox-trial\/\">Clinical Trials<\/a> The trial involved 227 children and 224 adults, with the significant immune responses in children aged two to five years. Bavarian Nordic has announced encouraging topline results from a clinical trial assessing its MVA-BN mpox\/smallpox vaccine in children aged between two and 11 years.<\/p>\n\n\n\n<p>The trial involved 460 participants across two cohorts, examining the immunogenicity and safety of two standard vaccine doses in both paediatric and adult populations aged 18\u201350 years.<\/p>\n\n\n\n<p>It was jointly funded by the Coalition for Epidemic Preparedness Innovations (CEPI) and took place at various locations in the Democratic Republic of Congo and Uganda.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Clinical Trials The trial involved 227 children and 224 adults, with the significant immune responses in children aged two to five years. Bavarian Nordic has announced encouraging topline results from a clinical trial assessing its MVA-BN mpox\/smallpox vaccine in children aged between two and 11 years. The trial involved 460 participants across two cohorts, examining [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[12],"tags":[],"class_list":["post-10511","post","type-post","status-publish","format-standard","hentry","category-monkeypox"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/10511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=10511"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/10511\/revisions"}],"predecessor-version":[{"id":10512,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/10511\/revisions\/10512"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=10511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=10511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=10511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}